A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma.
Fehniger TA, Larson S, Trinkaus K, Siegel MJ, Cashen AF, Blum KA, Fenske TS, Hurd DD, Goy A, Schneider SE, Keppel CR, Wagner-Johnston ND, Carson KR, Bartlett NL.
Fehniger TA, et al. Among authors: bartlett nl.
Blood. 2011 Nov 10;118(19):5119-25. doi: 10.1182/blood-2011-07-362475. Epub 2011 Sep 21.
Blood. 2011.
PMID: 21937701
Free PMC article.
Clinical Trial.